Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Chinese drug maker Akeso, whose new cancer drug has outperformed a leading Western peer in clinical studies, is being hailed ...

American biggies are joining hands with Chinese companies. AbbVie signed a deal with Simcere Zaiming for a multiple myeloma ...

Bengaluru: Prayoga Institute of Education Research on Friday announced its partnership with Merck, a science and technology ...

Value investing has long been a preferred strategy among investors, largely influenced by Warren Buffett, who continues to ...

It’s important to note that Zervos praised Cuggino’s diversified portfolio approach, particularly his use of hedges and fixed ...

Approximately 163 employees will be impacted by the pending closure of Merck’s Cherokee plant with layoffs set to begin in ...

The combination demonstrated non-inferiority to comparator antiretroviral therapies, meeting the primary efficacy success ...

White House reports declining inflation and job market gains under Trump's policies, with added border security success.

The current Wall Street sell-off has wiped out billions in market value, hammering tech giants, banks, and airlines while ...

Shares of Merck & Co. Inc. MRK slipped 1.46% to $93.35 Wednesday, on what proved to be an all-around mixed trading session ...